Rockwell Medical (RMTI) Competitors $1.07 -0.05 (-4.46%) Closing price 07/25/2025 04:00 PM EasternExtended Trading$1.06 -0.02 (-1.40%) As of 07/25/2025 07:42 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock RMTI vs. ARAY, RSLS, ABT, ISRG, BSX, SYK, MDT, BDX, EW, and IDXXShould you be buying Rockwell Medical stock or one of its competitors? The main competitors of Rockwell Medical include Accuray (ARAY), ReShape Lifesciences (RSLS), Abbott Laboratories (ABT), Intuitive Surgical (ISRG), Boston Scientific (BSX), Stryker (SYK), Medtronic (MDT), Becton, Dickinson and Company (BDX), Edwards Lifesciences (EW), and IDEXX Laboratories (IDXX). These companies are all part of the "health care equipment" industry. Rockwell Medical vs. Its Competitors Accuray ReShape Lifesciences Abbott Laboratories Intuitive Surgical Boston Scientific Stryker Medtronic Becton, Dickinson and Company Edwards Lifesciences IDEXX Laboratories Accuray (NASDAQ:ARAY) and Rockwell Medical (NASDAQ:RMTI) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, risk, profitability, institutional ownership, analyst recommendations, dividends, media sentiment and earnings. Do insiders and institutionals hold more shares of ARAY or RMTI? 64.1% of Accuray shares are owned by institutional investors. Comparatively, 23.3% of Rockwell Medical shares are owned by institutional investors. 4.2% of Accuray shares are owned by insiders. Comparatively, 3.6% of Rockwell Medical shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term. Which has preferable valuation & earnings, ARAY or RMTI? Rockwell Medical has lower revenue, but higher earnings than Accuray. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAccuray$446.55M0.31-$15.55MN/AN/ARockwell Medical$101.49M0.36-$480KN/AN/A Do analysts recommend ARAY or RMTI? Rockwell Medical has a consensus price target of $4.00, suggesting a potential upside of 273.83%. Given Rockwell Medical's stronger consensus rating and higher probable upside, analysts plainly believe Rockwell Medical is more favorable than Accuray.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Accuray 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Rockwell Medical 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 1 Strong Buy rating(s) 3.33 Which has more risk & volatility, ARAY or RMTI? Accuray has a beta of 1.26, indicating that its stock price is 26% more volatile than the S&P 500. Comparatively, Rockwell Medical has a beta of 1.57, indicating that its stock price is 57% more volatile than the S&P 500. Does the media prefer ARAY or RMTI? In the previous week, Accuray had 1 more articles in the media than Rockwell Medical. MarketBeat recorded 2 mentions for Accuray and 1 mentions for Rockwell Medical. Rockwell Medical's average media sentiment score of 1.89 beat Accuray's score of 1.77 indicating that Rockwell Medical is being referred to more favorably in the news media. Company Overall Sentiment Accuray Very Positive Rockwell Medical Very Positive Is ARAY or RMTI more profitable? Accuray has a net margin of 0.14% compared to Rockwell Medical's net margin of -0.27%. Accuray's return on equity of 1.43% beat Rockwell Medical's return on equity.Company Net Margins Return on Equity Return on Assets Accuray0.14% 1.43% 0.14% Rockwell Medical -0.27%-0.90%-0.47% SummaryRockwell Medical beats Accuray on 8 of the 15 factors compared between the two stocks. Get Rockwell Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for RMTI and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding RMTI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart RMTI vs. The Competition Export to ExcelMetricRockwell MedicalMED PRODUCTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$38.28M$10.55B$5.70B$9.50BDividend YieldN/A2.00%4.58%4.01%P/E RatioN/A17.0728.1020.05Price / Sales0.3629.17429.0189.19Price / Cash8.8623.0336.2258.56Price / Book1.063.698.665.87Net Income-$480K$234.77M$3.25B$258.55M7 Day Performance-2.73%6.32%4.22%3.73%1 Month Performance32.26%7.94%10.51%11.75%1 Year Performance-43.39%-13.57%34.40%18.03% Rockwell Medical Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)RMTIRockwell Medical3.9965 of 5 stars$1.07-4.5%$4.00+273.8%-42.2%$38.28M$101.49M0.00300Positive NewsARAYAccuray3.1256 of 5 stars$1.36flatN/A-27.3%$140.10M$465.25M0.001,040News CoveragePositive NewsRSLSReShape Lifesciences0.4256 of 5 stars$2.39+0.4%N/A-99.2%$5.71M$8.01M-0.0150Positive NewsABTAbbott Laboratories4.9902 of 5 stars$132.05+0.0%$143.11+8.4%+19.4%$229.74B$42.34B17.13114,000ISRGIntuitive Surgical4.7034 of 5 stars$516.44+0.9%$592.86+14.8%+13.5%$185.10B$8.35B75.7215,638Trending NewsEarnings ReportAnalyst ForecastInsider TradeAnalyst RevisionBSXBoston Scientific4.6348 of 5 stars$104.39+1.1%$116.09+11.2%+42.8%$154.43B$16.75B76.1953,000Trending NewsEarnings ReportAnalyst ForecastAnalyst RevisionSYKStryker4.5365 of 5 stars$391.46+0.5%$428.55+9.5%+23.2%$149.41B$22.60B52.9053,000Positive NewsUpcoming EarningsMDTMedtronic4.6569 of 5 stars$89.73-0.2%$97.47+8.6%+18.5%$115.08B$33.54B24.7995,000Positive NewsBDXBecton, Dickinson and Company4.8276 of 5 stars$177.15+0.7%$219.22+23.7%-20.3%$50.77B$20.87B33.8174,000Positive NewsDividend AnnouncementInsider TradeHigh Trading VolumeEWEdwards Lifesciences4.3573 of 5 stars$78.35+0.4%$80.40+2.6%+33.9%$45.96B$5.44B11.1915,800Trending NewsEarnings ReportAnalyst ForecastGap UpIDXXIDEXX Laboratories3.5802 of 5 stars$531.42-0.4%$558.11+5.0%+20.1%$42.74B$3.93B49.1111,000Positive News Related Companies and Tools Related Companies Accuray Alternatives ReShape Lifesciences Alternatives Abbott Laboratories Alternatives Intuitive Surgical Alternatives Boston Scientific Alternatives Stryker Alternatives Medtronic Alternatives Becton, Dickinson and Company Alternatives Edwards Lifesciences Alternatives IDEXX Laboratories Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:RMTI) was last updated on 7/26/2025 by MarketBeat.com Staff From Our PartnersTrump's 2025 Economic Revolution Is Here Are Your Retirement Savings Ready?Time is short. Trump's reforms may be coming fast—and the financial system roller coaster may be a ride that y...Create New Advertiser | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredBREAKING: The House just passed 3 pro-crypto bills!Experts Believe Altcoin Season is Here! With this new legislation in effect, crypto experts across the coun...Crypto 101 Media | Sponsored[Shocking New Report] U.S. Dollar To Crash?The "Death Spiral" Threatening Your Savings But this time, it's not just Dalio ringing the alarm bells…GoldCo Precious Metals | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Rockwell Medical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Rockwell Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
